Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

Plethysmograph Market Size to Grow by USD 16.47 Million, ACI Medical LLC and COSMED Srl Among Key Vendors - Technavio


NEW YORK, Aug. 16, 2022 /PRNewswire/ -- A plethysmograph is a non-invasive, low-cost device that is used to measure the volume changes in different parts of the body, resulting from fluctuations in the amount of blood or air. The device uses blood pressure cuffs and sensors. It is used for the diagnosis of various lung and vascular diseases

 

The plethysmograph market size is expected to grow by USD 16.47 million from 2021 to 2026. In addition, the growth momentum of the market will accelerate at a CAGR of 3.17% during the forecast period. according to Technavio.

Get a comprehensive report summary describing the market size and forecast along with research methodology. The FREE sample report is available in PDF format

Driver and Challenge

The increasing incidence and prevalence of lung and vascular diseases is driving the growth of the market. The number of people with lung and vascular diseases is rising due to factors such as obesity, smoking, sedentary lifestyles, environmental issues, lack of physical activity, alcohol consumption, and unhealthy eating habits. Hence, the availability of advanced diagnostic devices such as plethysmographs will drive the global plethysmograph market.

Limitations and complications associated with plethysmographs will challenge the growth of the market. If a patient moves when a body plethysmograph is used for the diagnosis of lungs and the presence of compressible material, unpredictable errors. Arterial puncture is one of the main complications. Patients may also experience claustrophobia, shortness of breath, anxiety, lightheadedness, and infection risks. All these limitations are expected to have an adverse impact on the global plethysmograph market.

Vendor Analysis

ACI Medical LLC, COSMED Srl, Ganshorn Medizin Electronic GmbH, Geratherm Medical AG, Medical Electronic Construction, medical equipment europe GmbH, MGC Diagnostics Corp., Morgan Scientific Inc., Piston Ltd., PulmOne Advanced Medical Devices Ltd., SCHILLER AG, Scireq, and Vyaire Medical Inc. are the main players in the market. The key offerings of some of these vendors are listed below:

This report provides a full list of key vendors, their strategies, and the latest developments. Buy Now to gain access to exclusive information about vendors

Plethysmograph Market Application Outlook (Revenue, USD mn, 2021-2026)
Plethysmograph Market End-user Outlook (Revenue, USD mn, 2021-2026)
Plethysmograph Market Geography Outlook (Revenue, USD mn, 2021-2026)

Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a FREE PDF Sample Report

Related Reports

Multimodal Imaging Market by Application and Geography - Forecast and Analysis 2022-2026

Home Blood Pressure Monitoring Devices Market by Type and Geography - Forecast and Analysis 2022-2026

Plethysmograph Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 3.17%

Market growth 2022-2026

USD 16.47 million

Market structure

Concentrated

YoY growth (%)

2.82

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 35%

Key consumer countries

US, Canada, Mexico, Germany, France, and China

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

ACI Medical LLC, COSMED Srl, Ganshorn Medizin Electronic GmbH, Geratherm Medical AG, Medical Electronic Construction, medical equipment europe GmbH, MGC Diagnostics Corp., Morgan Scientific Inc., Piston Ltd., PulmOne Advanced Medical Devices Ltd., SCHILLER AG, Scireq, and Vyaire Medical Inc.

Market dynamics

Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Table of Contents

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Five Forces Analysis

5 Market Segmentation by Application

6 Market Segmentation by End-user

7 Customer Landscape

8 Geographic Landscape

9 Drivers, Challenges, and Trends

10 Vendor Landscape

11 Vendor Analysis

12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio


These press releases may also interest you

at 09:41
Hyundai Bioscience announced on April 25th that, after multiple consultations with global clinical research organizations (CRO), it has decided to conduct clinical trials for its 'niclosamide-based Dengue antiviral' in...

at 09:35
Inocras, a leading AI-driven whole genome testing company, proudly announces the launch of CancerVision and RareVision, its flagship whole genome diagnostics solutions in solid tumor cancer and rare disease, respectively. CancerVision and...

at 09:30
PossibleNOWtm, the leading provider of enterprise consent and preference management solutions, today announced the launch of a program to enable companies to quickly capture express written consent. This will provide the ability for Third-Party...

at 09:30
Envisagenics, an AI-driven biotechnology company, today announced the publication in the journal Molecular Systems Biology of study results evaluating the company's SpliceCore AI/ML platform in Triple Negative Breast Cancer (TNBC). This study...

at 09:30
Co-Diagnostics, Inc. , a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its first quarter 2024 financial results on Thursday, May 9, 2024, after the...

at 09:20
Coronis Health, a trusted partner for laboratory and pathology revenue cycle management (RCM), will be a leading voice at the upcoming Executive War College (EWC) 2024 conference from April 30 to May 1 in New Orleans. As the premier forum for...



News published on and distributed by: